Xarelto Compensation Evaluation

Act Now!

Complete this brief survey today to have your case evaluated

Survey Submission Progress:
In January, 2014, the U.S. Food and Drug Administration (FDA) warned of an increased risk of bleeding while taking rivaroxaban (commonly known as Xarelto).

If you or a loved one experienced bleeding or other serious side effects while using Xarelto, please complete this compensation evaluation.

Please note: completion of this evaluation does not guarantee compensation. Each project has specific qualifying criteria and the criteria may change from time-to-time. In some instances, users who are not immediately contacted may be contacted at a later date.

*Source: NY Times 2014 http://goo.gl/FOUAsR